SHARON BODE: Open Payments
NPI 1932179751 · ELGIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,405 in 41 payments from 18 companies in 2025. Trend: 2023 $1,050 · 2024 $1,968 · 2025 $1,405
Food & beverage: $1,306Education: $99
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $351 |
| Edwards Lifesciences Corporation | 2 | $208 |
| Actelion Pharmaceuticals US, Inc. | 2 | $169 |
| Novo Nordisk Inc | 2 | $138 |
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| BridgeBio Pharma, Inc. | 1 | $50 |
| HEARTFLOW, INC. | 2 | $44 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
Products named: REPATHA, SAPIEN 3 Ultra RESILIA, Ozempic, OPSUMIT, FARXIGA, UPTRAVI, LEQVIO, ELIQUIS.
Industry payments across IL — which companies pay providers there.
